Literature DB >> 29679473

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method.

Nobuharu Tamaki1, Yohei Koizumi2, Masashi Hirooka2, Norihisa Yada3, Hitomi Takada1, Osamu Nakashima4, Masatoshi Kudo3, Yoichi Hiasa2, Namiki Izumi1.   

Abstract

AIM: The present study has developed and evaluated the effectiveness of a new echo attenuation measurement function combined with an ultrasonic diagnostic system for the accurate diagnosis of liver steatosis.
METHODS: A multicenter prospective study involving patients with chronic hepatitis was carried out. All patients underwent liver biopsy, and attenuation coefficient (ATT) was measured on the same day. The fat area (%) of biopsy specimens was quantitatively evaluated. Correlations between ATT, steatosis grade, and fat area were evaluated.
RESULTS: A total of 351 patients were enrolled in this study. The median values of fat area for steatosis grades S0, S1, S2, and S3 were 0.6%, 3.2%, 6.4%, and 15.5%, respectively. A significant correlation was found between fat area and steatosis grade (P < 0.001). Similarly, the median values of ATT for steatosis grades S0, S1, S2, and S3 were 0.55, 0.63, 0.69, and 0.85 dB/cm/MHz, respectively, and ATT increased with an increase in the steatosis grade (P < 0.001). Attenuation coefficient was significantly correlated with fat area (r = 0.50, P < 0.001). The area under the receiver operating characteristic curve corresponding to S ≥ 1, S ≥ 2, and S ≥ 3 were 0.79, 0.87, and 0.96, respectively. Similarly, the sensitivity and specificity of S ≥ 1, S ≥ 2, and S ≥ 3 were 72%, 82%, and 87% and 72%, 82%, and 89%, respectively.
CONCLUSIONS: The newly developed ATT measurement for evaluation of liver steatosis was closely correlated with steatosis grade and automated quantification of fat area, and it provides clinically relevant information.
© 2018 The Japan Society of Hepatology.

Entities:  

Keywords:  NAFLD; attenuation measurement; liver steatosis

Year:  2018        PMID: 29679473     DOI: 10.1111/hepr.13179

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  17 in total

Review 1.  Efficacy of B-mode ultrasound-based attenuation for the diagnosis of hepatic steatosis: a systematic review/meta-analysis.

Authors:  Masashi Hirooka; Yohei Koizumi; Kotarou Sunago; Yoshiko Nakamura; Kana Hirooka; Takao Watanabe; Osamu Yoshida; Yoshio Tokumoto; Masanori Abe; Yoichi Hiasa
Journal:  J Med Ultrason (2001)       Date:  2022-03-03       Impact factor: 1.314

2.  Correlation between hepatorenal index and attenuation imaging for assessing hepatic steatosis.

Authors:  Shrivuthsun Srigandan; Marilyn Zelesco; Steven Abbott; Christopher J Welman
Journal:  Australas J Ultrasound Med       Date:  2022-07-01

3.  Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.

Authors:  Jinho Jung; Aiguo Han; Egbert Madamba; Ricki Bettencourt; Rohan R Loomba; Andrew S Boehringer; Michael P Andre; John W Erdman; William D O'Brien; Kathryn J Fowler; Claude B Sirlin; Rohit Loomba
Journal:  Radiology       Date:  2022-03-29       Impact factor: 29.146

Review 4.  Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.

Authors:  Nobuharu Tamaki; Veeral Ajmera; Rohit Loomba
Journal:  Nat Rev Endocrinol       Date:  2021-11-23       Impact factor: 47.564

Review 5.  Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease.

Authors:  Nobuharu Tamaki; Masayuki Kurosaki; Yutaka Yasui; Kaoru Tsuchiya; Namiki Izumi
Journal:  J Med Ultrason (2001)       Date:  2021-06-24       Impact factor: 1.314

6.  Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease.

Authors:  Nobuharu Tamaki; Nagambika Munaganuru; Jinho Jung; Aed Qas Yonan; Rohan R Loomba; Richele Bettencourt; Veeral Ajmera; Mark A Valasek; Cynthia Behling; Claude B Sirlin; Rohit Loomba
Journal:  Gut       Date:  2021-04-21       Impact factor: 23.059

7.  Analysis of liver steatosis analysis and controlled attenuation parameter for grading liver steatosis in patients with chronic hepatitis B.

Authors:  Xinping Ren; Shujun Xia; Lu Zhang; Ruokun Li; Wei Zhou; Ri Ji; Jianqiao Zhou; Jingyan Tian; Weiwei Zhan
Journal:  Quant Imaging Med Surg       Date:  2021-02

8.  Quantification of Liver Fibrosis, Steatosis, and Viscosity Using Multiparametric Ultrasound in Patients with Non-Alcoholic Liver Disease: A "Real-Life" Cohort Study.

Authors:  Alexandru Popa; Felix Bende; Roxana Șirli; Alina Popescu; Victor Bâldea; Raluca Lupușoru; Radu Cotrău; Renata Fofiu; Camelia Foncea; Ioan Sporea
Journal:  Diagnostics (Basel)       Date:  2021-04-26

Review 9.  Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases.

Authors:  Nobuharu Tamaki; Masayuki Kurosaki; Rohit Loomba; Namiki Izumi
Journal:  Ann Lab Med       Date:  2020-08-25       Impact factor: 3.464

10.  Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience.

Authors:  Ioan Sporea; Ruxandra Mare; Alina Popescu; Silviu Nistorescu; Victor Baldea; Roxana Sirli; Adina Braha; Alexandra Sima; Romulus Timar; Raluca Lupusoru
Journal:  J Clin Med       Date:  2020-04-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.